Cargando…

Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease: A Population-Based Case–Control Study in Taiwan

The aim of this study was to evaluate the Parkinson disease (PD) prevalence of cognitive impairment in Taiwan. The case–control study consisted of 6177 cognitive impairment patients and 24,708 noncognitive impairment as controls for the period of 2006 to 2010 and both of the groups aged ≥50 years. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu-Ching, Wu, Shwu-Tzy, Lin, Juei-Jueng, Lin, Che-Chen, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603038/
https://www.ncbi.nlm.nih.gov/pubmed/25929923
http://dx.doi.org/10.1097/MD.0000000000000782
_version_ 1782394849026113536
author Huang, Yu-Ching
Wu, Shwu-Tzy
Lin, Juei-Jueng
Lin, Che-Chen
Kao, Chia-Hung
author_facet Huang, Yu-Ching
Wu, Shwu-Tzy
Lin, Juei-Jueng
Lin, Che-Chen
Kao, Chia-Hung
author_sort Huang, Yu-Ching
collection PubMed
description The aim of this study was to evaluate the Parkinson disease (PD) prevalence of cognitive impairment in Taiwan. The case–control study consisted of 6177 cognitive impairment patients and 24,708 noncognitive impairment as controls for the period of 2006 to 2010 and both of the groups aged ≥50 years. The multivariable logistic regression analyses were used to estimate the odds ratio (OR) for cognitive impairment, and the 95% confidence intervals (CIs) among patients with PD were compared with those of non-PD patients. PD (adjusted odds ratio [aOR] is 3.07, 95% CI 2.76–3.41) is the one of the most contributed risk factors for cognitive impairment. Besides, we found a remarkable result of the diagnosed cognitive impairment of PD that was found highest in the first 6 months (aOR 11.98, 95% CI 8.51–16.86) and then decrease the incident year by year. The PD prevalence in a patient with cognitive impairment in our data present is 12.1% lower than those with truly dementia published previously and documented by western studies. We found a remarkable result of the diagnosed cognitive impairment of PD that was found highest in the first 6 months and then decrease the incident year by year.
format Online
Article
Text
id pubmed-4603038
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46030382015-10-27 Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease: A Population-Based Case–Control Study in Taiwan Huang, Yu-Ching Wu, Shwu-Tzy Lin, Juei-Jueng Lin, Che-Chen Kao, Chia-Hung Medicine (Baltimore) 5300 The aim of this study was to evaluate the Parkinson disease (PD) prevalence of cognitive impairment in Taiwan. The case–control study consisted of 6177 cognitive impairment patients and 24,708 noncognitive impairment as controls for the period of 2006 to 2010 and both of the groups aged ≥50 years. The multivariable logistic regression analyses were used to estimate the odds ratio (OR) for cognitive impairment, and the 95% confidence intervals (CIs) among patients with PD were compared with those of non-PD patients. PD (adjusted odds ratio [aOR] is 3.07, 95% CI 2.76–3.41) is the one of the most contributed risk factors for cognitive impairment. Besides, we found a remarkable result of the diagnosed cognitive impairment of PD that was found highest in the first 6 months (aOR 11.98, 95% CI 8.51–16.86) and then decrease the incident year by year. The PD prevalence in a patient with cognitive impairment in our data present is 12.1% lower than those with truly dementia published previously and documented by western studies. We found a remarkable result of the diagnosed cognitive impairment of PD that was found highest in the first 6 months and then decrease the incident year by year. Wolters Kluwer Health 2015-05-01 /pmc/articles/PMC4603038/ /pubmed/25929923 http://dx.doi.org/10.1097/MD.0000000000000782 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 5300
Huang, Yu-Ching
Wu, Shwu-Tzy
Lin, Juei-Jueng
Lin, Che-Chen
Kao, Chia-Hung
Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease: A Population-Based Case–Control Study in Taiwan
title Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease: A Population-Based Case–Control Study in Taiwan
title_full Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease: A Population-Based Case–Control Study in Taiwan
title_fullStr Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease: A Population-Based Case–Control Study in Taiwan
title_full_unstemmed Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease: A Population-Based Case–Control Study in Taiwan
title_short Prevalence and Risk Factors of Cognitive Impairment in Parkinson Disease: A Population-Based Case–Control Study in Taiwan
title_sort prevalence and risk factors of cognitive impairment in parkinson disease: a population-based case–control study in taiwan
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603038/
https://www.ncbi.nlm.nih.gov/pubmed/25929923
http://dx.doi.org/10.1097/MD.0000000000000782
work_keys_str_mv AT huangyuching prevalenceandriskfactorsofcognitiveimpairmentinparkinsondiseaseapopulationbasedcasecontrolstudyintaiwan
AT wushwutzy prevalenceandriskfactorsofcognitiveimpairmentinparkinsondiseaseapopulationbasedcasecontrolstudyintaiwan
AT linjueijueng prevalenceandriskfactorsofcognitiveimpairmentinparkinsondiseaseapopulationbasedcasecontrolstudyintaiwan
AT linchechen prevalenceandriskfactorsofcognitiveimpairmentinparkinsondiseaseapopulationbasedcasecontrolstudyintaiwan
AT kaochiahung prevalenceandriskfactorsofcognitiveimpairmentinparkinsondiseaseapopulationbasedcasecontrolstudyintaiwan